A comparison of the clinical efficacy and safety of intranasal fluticasone propionate and antihistamines in the treatment of rhinitis

Allergy: European Journal of Allergy and Clinical Immunology, Supplement

Volumn 55, Issue 62, 2000, Pages 12-14

  Foresi, A ^a  

^a Servizio di Fisiopatologia Respiratoria Modulo di Allergologia E d'Immunopatologia Polmonare   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHISTAMINIC AGENT; CETIRIZINE; FLUTICASONE PROPIONATE; LEVOCABASTINE; LORATADINE; PLACEBO; STEROID; TERFENADINE;

ALLERGIC RHINITIS; CLINICAL TRIAL; CONFERENCE PAPER; DRUG EFFECT; DRUG EFFICACY; DRUG SAFETY; DRUG URINE LEVEL; HUMAN; PRIORITY JOURNAL; QUALITY OF LIFE; RHINOMANOMETRY;

EID: 0033919593     PISSN: 01081675     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1398-9995.2000.055suppl62012.x     Document Type: Conference Paper

References (19)

1. DYKEWICZ MS, FINEMAN S, SKONER DP, et al. Diagnosis and management of rhinitis: complete guidelines of the Joint Task Force on Practice Parameters in Allergy, Asthma and Immunology. American Academy of Allergy, Asthma and Immunology. Ann Allergy Asthma Immunol 1998;81(5 Pt 2):478-518.
2. BOUSQUET J, KNANI J, DHIVERT H, et al. Quality of life in asthma. I. Internal consistency and validity of the SF-36 questionnaire. Am J Respir Crit Care Med 1994-149: 371-375.
3. RAY NF, BARANIUK JN, THAMER M, et al. Direct expenditures for the treatment of allergic rhinoconjunctivitis in 1996, including contribution of related airway illness. J Allergy Clin Immunol 1999;103: 401-407.
4. International Rhinitis Management Working Group. International Consensus Report on the Diagnosis and Management of rhinitis. Allergy 1994;49 Suppl 19:1-34.
5. VERVLOET D, CHARPIN D, DESFOURGERES J-L. Intranasal fluticasone once daily compared with once-daily cetirizine in the treatment of seasonal allergic rhinitis. Clin Drug Invest 1997;13:291-298.
6. JORDANA G, DOLOVICH J, BRISCOE MP, et al. Intranasal fluticasone propionate versus loratadine in the treatment of adolescent patients with seasonal allergic rhinitis. J Allergy Clin Immunol 1996;97:588-595.
7. DARNELL R, PÉCOUD A, RICHARDS DH. A double-blind comparison of fluticasone propionate aqueous nasal spray, terfenadine tablets and placebo in the treatment of patients with seasonal allergic rhinitis to grass pollen. Clin Exp Allergy 1994;24:1144-1150.
8. ORTOLANI C, FORESI A, DI LORENZO G, et al. A double-blind comparison of treatment with fluticasone propionate and levocabastine in patients with seasonal rhinitis. Allergy 1999;54:1175-1180.
9. RATNER PH, VAN BAVEL JH, MARTIN BG, et al. A comparison of the efficacy of fluticasone propionate aqueous nasal spray and loratadine, alone and in combination, for the treatment of seasonal allergic rhinitis. J Fam Pract 1998;47:118-125.
10. BELLING U. Once daily treatment with fluticasone propionate aqueous nasal spray or astemizole tablets for seasonal rhinitis. Clin Exp Allergy 1990;20 Suppl 10:98.
11. KOZMA CM, SCHULZ RM, SCLAR DA, KRAL KM, MACKOWIAK JI. A comparison of costs and efficacy of intranasal fluticasone propionate and terfenadine tablets for seasonal allergic rhinitis. Clin Ther 1996;18:334-346.
12. BRONSKY EA, DOCKHORN RJ, MELTZER EO, et al. Fluticasone propionate aqueous nasal spray compared with terfenadine tablets in the treatment of seasonal allergic rhinitis. J Allergy Clin Immunol 1996;97:915-921.
13. GÉHANNO P, DESFOURGERES J-L. Fluticasone propionate aqueous nasal spray compared with oral loratadine in patients with seasonal allergic rhinitis. Allergy 1997;52:445-450.
14. COOK C, WISNIEWSKI M, COX F, REED K, ROGENES P. Intranasal fluticasone propionate (FP) is more effective than loratadine (LOR) for the treatment of seasonal allergic rhinitis. Allergy 1996;51 Suppl 31:152.
15. GOODWIN B, BOWER B, HAMPEL F, COOK C, WESTLUND R, COX F. Superior improvement in disease-specific quality of life for SAR patients receiving intranasal fluticasone vs loratadine tablets. J Allergy Clin Immunol 1997;99:S270.
16. VAN BAVEL J, FINDLAY SR, HAMPEL FC, JR, et al. Intranasal fluticasone propionate is more effective than terfenadine tablets for seasonal allergic rhinitis. Arch Intern Med 1994;154:2699-2704.
17. MCDOWELL JE, MACHIE AE, VENTRESCA GP, BYE A. Pharmacokinetics and bioavailability of intranasal fluticasone in humans. Pharmacokinetics 1997;14:44-52.
18. FORESI A, PELUCCHI, GHERSON G, MASTROPASQUA B, CHIAPPARINO A, TESTI R. Once daily intranasal fluticasone propionate (200 μg) reduces nasal symptoms and inflammation but also attenuates the increase in bronchial responsiveness during the pollen season in allergic rhinitis. J Allergy Clin Immunol 1996;98:274-282.
19. PASSALACQUA G, ALBANO M, CANONICA GW, et al. Inhaled and nasal corticosteroids: safety aspects. Allergy 2000;55:16-33.